Altogether, this suggested that pentoxifylline may synergize with 5-FU by reducing the secreted IL-6 within the 5-FU treated CRC PDOs and thereby attenuating STAT3 signaling and the increase of chemoresistant ALDHhigh cells. The gene discussed is IL6; the disease is colorectal carcinoma.